Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Merger cheer, Sanofi lift European shares; Fed in focus

Published 07/29/2019, 04:50 AM
Updated 07/29/2019, 04:56 AM
Merger cheer, Sanofi lift European shares; Fed in focus

By Susan Mathew and Medha Singh

(Reuters) - European shares recovered from early losses on Monday, fueled by a surge in the London Stock Exchange Group on its potential deal to buy financial data firm Refinitiv, while investors waited anxiously for an expected U.S. interest rate cut.

Shares of LSE (L:LSE) surged 14.6% to an all-time high after the exchange operator said it was in discussions to buy Refinitiv Holdings from U.S. buyout fund Blackstone Group (N:BX) for $27 billion, including debt.

That helped London's FTSE (FTSE) rise 1% and outperform major European peers, with other deal talks and weakness in the British pound also supporting the blue-chip index.

Britain's Just Eat (L:JE) soared 25.3% on news that it was in talks to be bought by rival online food delivery firm Takeaway.com (AS:TKWY) in a potential 8.2-billion-pound ($10.1 billion) all-share deal.

The pan-European stocks benchmark index (STOXX) was up 0.2% by 0818 GMT at the start of a week that is expected to be dominated by meetings at major central banks.

The U.S. Federal Reserve is widely expected to lower rates this Wednesday for the first time in a decade, but investors will look for clues on its future rate plans. Last week, European Central Bank chief Mario Draghi disappointed investors with less-dovish-than-expected remarks.

Stocks have rallied since a steep fall in May on hopes that major central banks would ease monetary policy to stave off any further slowing in global growth as trade war risks persist.

Meanwhile, the Bank of England on Thursday is expected to swim against the tide of looser policy sweeping major central banks and keep alive the prospect of future rate hikes.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

U.S. and Chinese trade negotiators will meet in Shanghai this week for their first in-person talks since a G20 truce last month, but expectations are low for a breakthrough.

"The upside is there won't be any new tariffs in the short to medium term," said Michael Hewson, chief market analyst at CMC Markets UK.

"But U.S. President Donald Trump has got what he wanted, which is a Fed rate cut. I don't think we are going to make any significant progress (on trade talks) before the year end."

Trade sensitive auto stocks (SXAP) fell 0.8%, the most among the major sectors.

Healthcare stock were mixed with Sanofi (PA:SASY) rising 2.8% after boosting its 2019 outlook, while Novartis (S:NOVN) dropped 1.3% as a trial for a new use of its Entresto heart drug failed.

Heineken (AS:HEIO) slumped 5.3% after the world's second largest brewer missed estimates for first-half profit.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.